These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 19188135)

  • 1. Osteonecrosis of the jaw under bisphosphonate and antiangiogenic therapies: cumulative toxicity profile?
    Ayllon J; Launay-Vacher V; Medioni J; Cros C; Spano JP; Oudard S
    Ann Oncol; 2009 Mar; 20(3):600-1. PubMed ID: 19188135
    [No Abstract]   [Full Text] [Related]  

  • 2. [Sunitinib and zoledronic acid induced osteonecrosis of the jaw].
    Soós B; Vajta L; Szalma J
    Orv Hetil; 2015 Nov; 156(46):1865-70. PubMed ID: 26548471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
    Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteonecrosis of the jaw after a single bisphosphonate infusion in a patient with metastatic renal cancer treated with sunitinib.
    Bozas G; Roy A; Ramasamy V; Maraveyas A
    Onkologie; 2010; 33(6):321-3. PubMed ID: 20523097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-induced palate osteonecrosis following nasal surgery.
    Balmor GR; Yarom N; Weitzen R
    Isr Med Assoc J; 2012 Mar; 14(3):193-4. PubMed ID: 22675864
    [No Abstract]   [Full Text] [Related]  

  • 6. Osteonecrosis of the jaw.
    Sari E; Bulut N; Altundag K
    J Am Dent Assoc; 2008 Apr; 139(4):398; author reply 398-400. PubMed ID: 18385020
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous bisphosphonates and osteonecrosis.
    Greenberg MS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Sep; 98(3):259-60. PubMed ID: 15356460
    [No Abstract]   [Full Text] [Related]  

  • 8. Bevacizumab, sunitinib: osteonecrosis of the jaw.
    Prescrire Int; 2011 Jun; 20(117):155. PubMed ID: 21682016
    [No Abstract]   [Full Text] [Related]  

  • 9. Worsening of osteonecrosis of the jaw during treatment with sunitinib in a patient with metastatic renal cell carcinoma.
    Brunello A; Saia G; Bedogni A; Scaglione D; Basso U
    Bone; 2009 Jan; 44(1):173-5. PubMed ID: 18849018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteonecrosis of the jaws in newly diagnosed multiple myeloma patients treated with zoledronic acid and thalidomide-dexamethasone.
    Tosi P; Zamagni E; Cangini D; Tacchetti P; Di Raimondo F; Catalano L; D'Arco A; Ronconi S; Cellini C; Offidani M; Perrone G; Ceccolini M; Brioli A; Tura S; Baccarani M; Cavo M
    Blood; 2006 Dec; 108(12):3951-2. PubMed ID: 17114572
    [No Abstract]   [Full Text] [Related]  

  • 11. New Non-Bisphosphonate Drugs that Produce Osteonecrosis of the Jaws.
    Ramírez L; López-Pintor RM; Casañas E; Arriba Ld; Hernández G
    Oral Health Prev Dent; 2015; 13(5):385-93. PubMed ID: 25884045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteonecrosis of the jaw and bisphosphonates.
    Durie BG; Katz M; Crowley J
    N Engl J Med; 2005 Jul; 353(1):99-102; discussion 99-102. PubMed ID: 16000365
    [No Abstract]   [Full Text] [Related]  

  • 13. [Avascular osteonecrosis of the jaws induced by diphosphonates].
    Lannoy D; Decaudin B; Barrier F; Bemba M; Wierre L; Pignon JM; Horrent S; Résibois JP; Wetterwald M; Odou P
    Therapie; 2006; 61(4):363-5. PubMed ID: 17124954
    [No Abstract]   [Full Text] [Related]  

  • 14. Diagnosis and Staging of Medication-Related Osteonecrosis of the Jaw.
    Ruggiero SL
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):479-87. PubMed ID: 26293329
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteonecrosis of the jaw and the use of antiangiogenic agents: just an association?
    Aragon-Ching JB; Dahut WL
    Oncologist; 2008 Dec; 13(12):1314; author reply 1315. PubMed ID: 19088325
    [No Abstract]   [Full Text] [Related]  

  • 16. The Role of Antiangiogenic Therapy in the Development of Osteonecrosis of the Jaw.
    Fantasia JE
    Oral Maxillofac Surg Clin North Am; 2015 Nov; 27(4):547-53. PubMed ID: 26515736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Bisphosphonates and osteonecrosis of the jaws in patients with myelomatosis].
    Neumann B; Gregersen H
    Ugeskr Laeger; 2006 May; 168(21):2078-9. PubMed ID: 16768928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Avascular osteonecrosis of the jaw as a side effect of bisphosphonate treatment.
    Bamias A; Terpos E; Dimopoulos MA
    Onkologie; 2010; 33(6):288-9. PubMed ID: 20523090
    [No Abstract]   [Full Text] [Related]  

  • 19. Osteonecrosis of the jaw and bisphosphonates.
    Woo SB; Hande K; Richardson PG
    N Engl J Med; 2005 Jul; 353(1):99-102; discussion 99-102. PubMed ID: 16003837
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral osteonecrosis associated with the use of zoledronic acid: first case of a patient with advanced pancreatic cancer and bone metastases.
    Smith A; Kressley A; Saif MW
    JOP; 2009 Mar; 10(2):212-4. PubMed ID: 19287122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.